LQDA
Liquidia Corp
NASDAQ · Healthcare · Biotechnology · US
$66.88
−2.21%Next report
Analyst consensus
- Next report date
- Nov 2, 2026
- EPS estimate
- $0.90
- Revenue estimate
- $205.9M
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- $0.74
- EPS estimate
- $0.76
- Revenue actual
- $171.7M
- Revenue estimate
- $168.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +31.0%
- Revenue beats (12Q)
- 7
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | $0.76 | $0.74 | Miss -2.37% | $171.7M |
| May 11, 2026 | $0.34 | $0.52 | Beat 52.94% | $132.9M |
| Mar 5, 2026 | $0.08 | $0.15 | Beat 87.50% | $92.0M |
| Aug 12, 2025 | -$0.43 | -$0.49 | Miss -13.95% | $8.8M |
| May 8, 2025 | -$0.42 | -$0.45 | Miss -7.14% | $3.1M |
| Mar 19, 2025 | -$0.38 | -$0.46 | Miss -21.05% | $2.9M |
| Nov 13, 2024 | -$0.37 | -$0.37 | In line | $4.4M |
| Mar 13, 2024 | -$0.23 | -$0.42 | Miss -82.61% | $4.5M |
| Aug 10, 2023 | -$0.17 | -$0.36 | Miss -111.76% | $4.8M |
| May 4, 2023 | -$0.18 | -$0.18 | In line | $4.5M |
| Mar 16, 2023 | -$0.17 | -$0.09 | Beat 47.06% | $5.4M |
| Aug 11, 2022 | -$0.24 | -$0.15 | Beat 37.50% | $3.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 2, 2026